Medical laboratory testing and techniques Books

Book SynopsisA respected resource for decades, the Guide for the Care and Use of Laboratory Animals has been updated by a committee of experts, taking into consideration input from the scientific and laboratory animal communities and the public at large. The Guide incorporates new scientific information on common laboratory animals, including aquatic species, and includes extensive references. It is organized around major components of animal use: *Key concepts of animal care and use. The Guide sets the framework for the humane care and use of laboratory animals. *Animal care and use program. The Guide discusses the concept of a broad Program of Animal Care and Use, including roles and responsibilities of the Institutional Official, Attending Veterinarian and the Institutional Animal Care and Use Committee. *Animal environment, husbandry, and management. A chapter on this topic is now divided into sections on terrestrial and aquatic animals and provides recommendations for housing and environment, Table of Contents1 Front Matter; 2 1 Key Concepts; 3 2 Animal Care and Use Program; 4 3 Environment, Housing, and Management; 5 4 Veterinary Care; 6 5 Physical Plant; 7 Addendum: Guide for the Care and Use of Laboratory Animals Eighth Edition; 8 Appendices; 9 Appendix A: Additional Selected References; 10 Appendix B: U.S. Government Principles for the Utilization and Care of Vertebrate Animals Used in Testing, Research, and Training; 11 Appendix C: Statement of Task; 12 Appendix D: About the Authors; 13 Index

Read more less

Book SynopsisCytopathology provides a wide-ranging overview of the microscopic study of normal and abnormal cells, showing how current visualization methods are used to study cell structure, and how early detection of abnormal cell pathology can lead to timely clinical interventions.Trade ReviewReview from previous edition The flow of information is excellent and the text is well-written... a good introductory text for undergraduates with an interest in cytology and for professionals in training. * Dr Lesley Walton, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University *Lucid, logical coverage of material, set out thoughtfully and supported by good illustrations and learning features that make the text student-friendly... a very useful undergraduate cytopathology textbook. * Dr Nicholas Vardaxis, Endeavour College of Natural Health *Clearly written, factual and concise. * Dr Patricia Gadsdon, FIBMS, School of Biological Sciences, Bangor University *Table of Contents1: Behdad Shambayati: Introduction: a glance at the past, a glimpse of the future 2: Andrew Evered & Behdad Shambayati: Preparation techniques 3: John Crossley & Beverley Crossley: The cervical screening process 4: Andrew Evered: Normal cervical cytology 5: Andrew Evered: Abnormal cervical cytology 6: John Crossley & Paul Cross: Quality issues in cervical screening and cytology 7: Andrew Evered: Diagnostic cytopathology 8: Behdad Shambayati: Cytology of urine 9: Behdad Shambayati: Serous effusions and peritoneal washings 10: Behdad Shambayati: Lower respiratory tract cytology 11: Behdad Shambayati: Fine needle aspiration cytology 12: Paul Cross & Behdad Shambayati: Cytology of head and neck 13: Stephen Blackman & Behdad Shambayati: Basic semen analysis 14: Behdad Shambayati: Cytology of the biliary tract and pancreas 15: Bruno Ping: Advances in cytopathology 16: Andrew Evered: Data analysis in cytopathology 17: Andrew Evered: Expertise in cytopathology

Read more less

Book Synopsis Concise, conversational, entertaining, and easy to use at any level of healthcare experience, The Only Diagnostic Lab Book You’ll Ever Need clarifies the when, where, why, and how of laboratory testing to help you make informed testing decisions and draw confident clinical conclusions.   This approachable how-to guide focuses on the most common and clinically useful diagnostic tests and panels employed in everyday healthcare practice, regardless of specialty, making it the ideal introduction for medical, PA, nurse practitioner, and nursing students embarking on their healthcare education. Residents, fellows, and practicing clinicians will find many new insights and clinical pearls that can immediately improve their practice and teaching. Straightforward, clinically oriented coverage walks you through selecting and employing the right diagnostic tests from the thousands available. The result is an informative, engaging text that will help you hone your clinical reasoning and streamline your approach to ordering and interpreting lab tests in the clinical decision-making process. Abundant illustrations, tables, and flow charts highlight key concepts in selecting and interpreting diagnostic lab tests. Lively, lighthearted text gets right to the point without compromising clarity or detail. Discussions emphasize what the tests actually mean within the relevant clinical context, stressing understanding over memorization; you will know what to do next, what to avoid, and why.

Read more less

Book SynopsisHistopathology describes the processes and practices that are central to the role of the histopathologist within a functioning diagnostic laboratory, from pre-sampling to diagnosis to laboratory management.Trade ReviewIt is very simply and clearly written in language that is easy to understand for the non-specialist. It describes day-to-day histopathology lab practice with clarity and the case studies are very helpful to illustrate the applications of the techniques. * Susan Brooks, Oxford Brookes University *The strength of the book is its detail. The book contains information that is completely lacking from other histopathology books. Overall I think that it is a great textbook for biomedical students and academics. * Akis Karakesisoglou, Durham University *Any potential biomedical scientist with an interest in histopathology, and sound knowledge of the contents of this well- written and nicely-illustrated text together with appropriate practical experience would be well on their way to becoming a valuable member of the team that comprises the core of todays histopathology laboratory. The text will make a valuable addition to any library associated with laboratories performing histopathological techniques. * Judy Brincat, Histology Group of Victoria *Table of Contents1: Dr Guy Orchard, Mr David Muskett, Dr Anne Warren: What is histopathology? 2: Mr David Muskett: Fixation and specimen handling 3: Ms Vanda McTaggart, Dr Sue Pritchard, Dr Anne Warren: Data recording and histopathology dissection 4: Mr David Muskett: Routine staining, processing and embedding 5: Mr David Muskett and Dr Guy Orchard: Special stains 6: Dr Guy Orchard , Mrs Chantell Hodgson, Mr Brian Nation: Artefacts 7: Dr Guy Orchard and Mr Mohammad Shams: Mohs procedures 8: Dr Merdol Ibrahim and Dr Guy Orchard: Immunocytochemical techniques 9: Mr David Muskett, Dr Guy Orchard, Dr Anne Warren: Analytical immunocytochemistry 10: Dr Tony Warford and Dr Emanuela Volpi: In situ hybridization: concepts and applications 11: Mr Brendan O'Sullivan and Dr Phillipe Taniere: Molecular diagnostics: techniques and applications 12: Dr Phillipe Taniere: Molecular diagnostics in action 13: Dr Guy Orchard and Dr Sue Pritchard: Histopathology reporting 14: Dr Guy Orchard: Microscopy and digital pathology 15: Prof David Furness: Electron microscopy in diagnosis 16: Ms Ishbel Gall and Dr Mike Osborne: Mortuary practice 17: Ms Sue Alexandra and Ms Patricia Fernando: Essentials of laboratory management

Read more less

Book SynopsisThis handbook is a definitive, up-to-date, and succinct text covering the legislative requirements, scientific foundations, and clinical good practice necessary for clinical, academic, and healthcare research.Trade ReviewThe Oxford Handbook of Clinical and Healthcare Research packs a lot of information into a literally hand-sized ... book, with precise writing." * Norman M. Goldfarb, Journal of clinical research best practises *A unique handbook that covers all the stages of clinical research along with a clear description of the regulations / processes that current researchers need to comply with. This truly addresses a much needed gap in the various research handbooks. * Dr Puja Myles, Associate Professor Health Protection and Epidemiology; Nottingham University *Table of Contents1. Research - How and Why ; 2. Navigating Research Methods: Basic concepts in biostatistics and epidemiology ; 3. Navigating Research Methods: Quantitative and clinical / epidemiological methods ; 4. Navigating Research Methods: Qualitative methods ; 5. Navigating Research Methods: Evidence Based Medicine (EBM) ; 6. Navigating Research Methods: Critical ap-praisal ; 7. Navigating Research Methods: Clinical Audit ; 8. Setting the scene and ICH-GCP in clinical and healthcare research ; 9. Informed consent in a research setting ; 10. Ethics of clinical and healthcare research: general considerations, Mental Capacity Act, Human Tissue Act ; 11. Role and Responsibilities: Investigators and Research Team ; 12. Role and Responsibilities: Sponsor ; 13. Monitoring ; 14. Clinical Trial Design ; 15. Clinical Trial Protocols: Study Protocol ; 16. Data Capture Tools: Case Report Form (CRF) ; 17. Clinical Trial Supplies: IMPs ; 18. IMP Accountability ; 19. Safety Reporting ; 20. Data management ; 21. Research Project Management ; 22. Essential Documents ; 23. Archiving ; 24. Audits and Inspections ; 25. Fraud and Misconduct ; 26. Authorship ; 27. Publication process ; 28. Start-up toolkit: from funding an idea, through implementation, to achieving an impact

Read more less

Book SynopsisTrade Review"It remains the worldwide standard in laboratory haematology and no haematologist should be without it!" "This is an excellent book for new learners or for experienced practitioners wanting an update/refresher. If you want a basic book covering all aspects of laboratory and clinical hematology, this is the one for you. If you are a student, this is a must have." -Valerie L. Ng, PhD MD (Alameda County Medical Center/Highland Hospital) Doody's Score: 94 - 4 Stars!Table of Contents1 Collection and handling of blood 2 Reference ranges and normal values 3 Basic haematological techniques 4 Preparation and staining methods for blood and bone marrow films 5 Blood cell morphology in health and disease 6 Supplementary techniques including blood parasite diagnosis 7 Bone marrow biopsy 8 Molecular and cytogenetic analysis 9 Iron deficiency anaemia and iron overload 10 Investigation of megaloblastic anaemia: cobalamin, folate and metabolite status 11 Laboratory methods used in the investigation of the haemolytic anaemias 12 Investigation of the hereditary haemolytic anaemias: membrane and enzyme abnormalities 13 Acquired haemolytic anaemias 14 Investigation of variant haemoglobins and thalassaemias 15 Erythrocyte and leucocyte cytochemistry 16 Immunophenotyping by flow cytometry 17 Diagnostic radioisotopes in haematology 18 Investigation of haemostasis 19 Investigation of a thrombotic tendency 20 Laboratory control of anticoagulant, thrombolytic and antiplatelet therapy 21 Blood cell antigens and antibodies: erythrocytes, platelets and neutrophils 22 Laboratory aspects of blood transfusion 23 Approach to the diagnosis and classification of blood cell disorders 24 Laboratory organisation, management and safety 25 Quality assurance 26 Haematology in under-resourced laboratories

Read more less

Book Synopsis

Read more less

Book SynopsisGood Manufacturing Practice (GMP) ensures medicinal products are produced consistently and controlled to the quality standards appropriate for their intended use and as required by product specifications or marketing authorization. Annex 11 details the European Medicines Agency (EMA) GMP requirements for computer systems.The purpose of Annex 11 is to provide the EMA healthcare industry with consistent criteria for effective implementation, control, and use of computer systems. EU Annex 11 Guide to Computer Validation Compliance for the Worldwide Health Agency GMP supplies practical information to facilitate compliance with computer system GMP requirements, while highlighting and integrating the Annex 11 guidelines into the computer compliance program.The ideas presented in this book are based on the author's 25 years of experience with computer validation in the healthcare industry with various computer systems development, maintenance, and quality functiTable of ContentsIntroduction. SLC, Computer Validation, and Annex 11. Annex 11 Principles. Risk Management. Personnel. Suppliers and Service Providers. Validation. Data. Accuracy Checks. Data Storage. Printouts. Audit Trails—Ensuring Data Integrity. Change and Configuration Management. Periodic Evaluation: Independent Review to Ensure Continued Validation of Computerized Systems. Security. Incident Management. Electronic Signatures: Electronic Signing Requirements. Batch Certification and Release. Business Continuity. Archiving. SLC Documentation. Relevant Procedural Controls. Maintaining the Validated State in Computer Systems. Annex 11 and the Cloud. EU GMP Chapter 4–Documentation and Annex 11. Annex 11 and Electronic Records Integrity. Annex 11 and 21 CFR Part 11: Comparisons for International Compliance.

Read more less

Book SynopsisFor around half of the couples who have trouble conceiving the cause of infertility is sperm-related. Intracytoplasmic sperm injection (ICSI) is the most common and successful treatment for male infertility. Here, the pioneers for the technique, along with authorities in the field, describe the underlying science of ICSI and other micromanipulation techniques. Practical advice for performing the techniques is covered in depth, including sperm selection, laser-assisted ICSI, and the use of piezo in ICSI. Examining the safety of ICSI in animal models as well as the impact of ICSI on the health and well-being of the children conceived through the procedure is discussed. This manual is an essential resource for clinical embryologists and laboratory personnel wishing to refine or develop techniques and improve outcomes.Table of ContentsForeword Zev Rosenwaks; 1. In-vitro fertilization and micromanipulation: The history that changed the treatment of male factor infertility Jacques Cohen; 2. Development of ICSI in human assisted reproduction Stephanie Cheung, Alessandra Parrella, Philip Xie, Sherina Lawrence, Mounia Haddad, Derek Keating, Zev Rosenwaks and Gianpiero D. Palermo; 3. Current ICSI applications and clinical outcomes Derek Keating, Stephanie Cheung, Philip Xie, June Wang, Zev Rosenwaks and Gianpiero D. Palermo; 4. Rescue ICSI of IVF failed-fertilized oocytes Carly Barber, Vivian Nguyen, Alexandrea Ramsey and Zsolt Peter Nagy; 5. High-magnification sperm selection before ICSI Pierre Vanderzwalmen, Barbara Wirleitner, Guy Cassuto, Romain Imbert and Maximillian Murtinger; 6. Laser-assisted ICSI Roberta Maggiulli, Simona Alfano, Erminia Alviggi, Gemma Fabozzi, Danilo Cimadomo, Filippo Maria Ubaldi and Laura Rienzi; 7. Piezo: The add-on to standardize ICSI procedure Tetsunori Mukaida, Kenichiro Hiraoka, Hideaki Watanabe, Kiyotaka Kawai and Csaba Pribenszky; 8. Artificial oocyte activation after ICSI Thomas Ebner; 9. Health of children born after Intracytoplasmic Sperm Injections (ICSI) Shahad Sabti and Alastair G. Sutcliffe; 10. Examining the safety of Intracytoplasmic Sperm Injection (ICSI) using animal models Laura Hewitson; 11. Cellular and molecular events after ICSI in clinically relevant animal models Lauren Hamilton, Richard J. Oko and Peter Sutovsky; 12. Micromanipulation, microinjection microscopes and systems for ICSI Steven D. Fleming; 13. Automation techniques and systems for ICSI Changsheng Dai, Zhuoran Zhang, Guanqiao Shan and Yu Sun; 14. Germline nuclear transfer technology to overcome mitochondrial diseases and female infertility Mao-Xing Tang, Annekatrien Boel, Paul Couke and Björn Heindryckx; 15. Nuclear transfer technology and its use in reproductive medicine Pasqualino Loi, Marta Czernik, Luca Palazzese, Pier Augusto Scapolo, Helena Fulka and Josef Fulka Jr; 16. The prospects of infertility treatment using 'artificial' eggs Katsuhiko Hayashi; Index.

Read more less

Book Synopsis

Read more less

Book SynopsisThis book provides useful information for bioanalytical / analytical scientists, analysts, quality assurance managers, and all personnel in bioanalytical laboratories through all aspects of bioanalytical technical and regulatory perspectives within bioanalytical operations and processes. Readers learn how to develop and implement strategies for routine, non-routine, and standard bioanalytical methods and on the entire equipment hardware and software qualification process. The book also gives guidelines on qualification of certified standards and in-house reference material as well as on people qualification. Finally, it guides readers through stressless internal and third party laboratory audits and inspections. It takes account to most national and international regulations and quality and accreditation standards, along with corresponding interpretation and inspection guides. The author elaborates on highly comprehensive content, making it easy not only to learn the subject but also tTrade Review Table of ContentsPreface xiii Acknowledgment xvii Contributors and Advisors xix 1 Introduction, Objectives, and Key Requirements for GLP Regulations 1 1.1 Introduction 1 1.1.1 Good Laboratory Practices 1 1.1.2 Bioanalytical Laboratories—Bioanalysis 4 1.1.3 Good Laboratory Practices Versus Bioanalytical Labs/ Bioanalysis 7 1.2 Objectives and Key Requirements for GLP Regulations 8 1.3 Fundamental Understanding of GLP Regulations and Principles 10 1.3.1 Elements of Good Laboratory Practices 11 1.4 Key Elements of Bioanalytical Methods Validation 16 1.4.1 Reference Standards 19 1.4.2 Method Development—Chemical/Chromatographic Assay 20 1.4.3 Calibration/Standard Curve 21 1.4.4 Stability 21 1.4.5 Reproducibility 23 1.4.6 Robustness or Ruggedness 23 1.5 Basic Principles of Bioanalytical Method Validation and Establishment 23 1.5.1 Specific Recommendations for Method Validation 24 1.5.2 Acceptance Criteria for Analytical Run 29 References 33 2 Historic Perspectives of GLP Regulations, Applicability, and Relation to Other Regulations 35 2.1 Historic Perspectives of GLP Regulations 35 2.1.1 Economic Assessment 39 2.1.2 Environmental Impact 40 2.2 Applicability and Relations to Other Regulations/Principles 42 2.2.1 GLP, GCP, GMP, and Part 11 42 2.2.2 General Terminologies and Definitions of GxPs (GLP, GCP, and cGMP) 47 2.3 Comparison of FDA GLP, EPA GLP Regulations, and OECD GLP Principles 47 2.3.1 US and OECD GLP Similarity and Differences 53 2.4 Applications of GLP to Multiple Site Studies 55 2.4.1 Roles and Responsibilities 57 2.4.2 Performance of the Studies 61 2.4.3 Applications of GLP to In Vitro Studies for Regulatory Submissions 64 2.5 21 CFR Part 11 in Relation to GLP Programs 66 2.5.1 A New Risk-Based Approach 67 2.5.2 Understanding Predicate Rule Requirements 67 2.5.3 21 CFR Part 11 Best Practices 68 2.5.4 Use of Electronic Signatures 71 2.6 GLP, cGMP, and ISO Applicabilities, Similarity, and Differences 74 2.6.1 GLPs, cGMPs, ISO 17025:2005: How Do They Differ? 74 2.6.2 GLPs Versus GMPs 74 2.6.3 GLPs Versus ISO/IEC 17025:2005 75 2.6.4 ISO Versus GLPs 76 2.7 Good Clinical Practices and Good Clinical Laboratory Practices 78 2.8 Gap and Current Initiatives on Regulating Laboratory Analysis in Support of Clinical Trials 80 References 84 3 GLP Quality System and Implementation 87 3.1 GLP Quality System 87 3.1.1 Regulatory Inspection for GLP Quality System 95 3.1.2 Good Laboratory Practice Inspections 99 3.1.3 GLP Quality System Objectives 103 3.2 Global GLP Regulations and Principles 106 3.2.1 General 106 3.2.2 Responsibilities and Compliance 107 3.2.3 Statement of Compliance in the Final Report 107 3.2.4 Protocol Approval 108 3.2.5 Assignment of Study Director 108 3.2.6 Laboratory Qualification/Certification 108 3.2.7 Authority Inspections 108 3.2.8 Archiving Requirements 108 3.3 Implementation of GLP Regulations and OECD Principles 109 3.3.1 Planning (Master Schedule) 114 3.3.2 Personnel Organization 115 3.3.3 Curriculum Vitae 115 3.3.4 Rules of the Conducts of Studies 116 3.3.5 Content of Study Protocol 116 3.3.6 Approval of Study Protocol 118 3.3.7 Distribution of Study Protocol 118 3.3.8 Protocol Amendment 118 3.3.9 Standard Operating Procedures 119 3.3.10 SOP System Overview 119 3.3.11 Characterization 121 3.3.12 Test Item/Article Control before Formulation 121 3.3.13 Preparation of the Dose Formulation 123 3.3.14 Sampling and Quality Control of Dose Formulation 125 3.4 Initiatives and Implementation of Bioanalytical Method Validation (Guidance for Industry BMV—May 2001) 126 3.4.1 Summary 127 References 128 4 Fundamental Elements and Structures for Regulated Bioanalytical Laboratories 131 4.1 Introduction 131 4.2 Fundamental Elements for Bioanalytical Laboratories 133 4.2.1 Document Retention and Archiving 136 4.3 Basic Requirements for GLP Infrastructure and Operations 139 4.4 GxP Quality Systems 143 4.4.1 Laboratory Instrument Qualification and Validation 149 4.4.2 Procedural Elements and Function that Maintain Bioanalytical Data Integrity for GLP Studies 150 References 166 5 Technical and Regulatory Aspects of Bioanalytical Laboratories 167 5.1 Fundamental Roles and Responsibilities of Bioanalytical Laboratories 167 5.1.1 Technical Functions of Bioanalytical Laboratories 168 5.1.2 Basic Processes in Bioanalytical Method Development, Validation, and Sample Analysis 173 5.2 Qualification of Personnel, Instrumentation, and Analytical Procedures 178 5.2.1 From Regulatory Perspectives: Personnel, Training, and Qualification 183 5.2.2 Facility Design and Qualifications 186 5.2.3 Equipment Design and Qualification 186 5.2.4 Analytical/Bioanalytical Method Qualification and Validation along with Related SOPs 197 5.3 Regulatory Compliance with GLP Within Bioanalytical Laboratories 204 5.4 Joint-Effort from Industries and Regulatory Agencies 206 5.4.1 Ligand-Binding Assays In-Study Acceptance Criteria 213 5.4.2 Determination of Metabolites during Drug Development 216 5.4.3 Incurred Sample Analysis 216 5.4.4 Documentation Issues 217 5.4.5 Analytical/Validation Reports 218 5.4.6 Source Data Documentation 218 5.4.7 Final Report Documentation 219 5.4.8 Stability Recommendation 219 5.4.9 Matrix Effects for Mass Spectrometric-Based Assays 221 5.4.10 System Suitability 222 5.4.11 Reference Standards 222 5.4.12 Validation Topics with No Consensus 222 5.4.13 Specific Criteria for Cross-Validation 223 5.4.14 Separate Stability Experiments Required at – 70°C if Stability Shown at – 20°C 223 5.4.15 Stability Criteria for Stock Solution Stability 224 5.4.16 Acceptance Criteria for Internal Standards 224 5.4.17 Summary 224 References 226 6 Competitiveness of Bioanalytical Laboratories—Technical and Regulatory Perspectives 229 6.1 Technical Aspect of Competitive Bioanalytical Laboratories 229 6.2 Bioanalytical Processes and Techniques 232 6.2.1 Sample Generation, Shipment, and Storage 232 6.2.2 Sample Preparation 233 6.3 Enhancing Throughput and Efficiency in Bioanalysis 243 6.3.1 Chromatographic Separation 244 6.3.2 Selective and Sensitive Detection 251 6.4 Technical Challenges and Issues on Regulated Bioanalysis 254 6.4.1 Matrix Effect 254 6.4.2 Method Validation and Critical Issues during Sample Analysis 256 6.4.3 Method Transfer 258 6.5 Regulatory Aspects of Competitive Bioanalytical Laboratories 264 6.5.1 General Consideration 264 6.5.2 Historical Perspective 265 6.5.3 Personnel—Training and Qualification 267 6.5.4 Facility—Design and Qualifications 269 6.5.5 Equipment Design and Qualification 270 6.5.6 Standard Operating Procedures 272 6.5.7 Laboratory/Facility Qualification Perspectives 272 6.6 Advanced/Competitive Bioanalytical Laboratories 277 6.6.1 Strategy Versus Tactics 278 6.6.2 Bioanalytical Laboratory Assessment 279 6.6.3 Capacity 279 6.6.4 Experience 280 6.6.5 Quality 281 6.6.6 Performance and Productivity Measures 281 6.6.7 Information Technology and Data Management 282 6.6.8 Communication 282 6.6.9 Financial Stability 283 6.6.10 Ease of Use 283 6.6.11 Contracting Bioanalytical Services 284 6.6.12 The Contracting Process 284 6.7 Applications and Advances in Biomarker and/or Ligand-Binding Assays within Bioanalytical Laboratories 286 References 290 7 Sponsor and FDA/Regulatory Agency GLP Inspections and Study Audits 297 7.1 GLP versus Biomedical Research Monitoring and Mutual Acceptance of Data for Global Regulations and Inspections 298 7.2 Purposes and Benefits of Regulatory Inspections/Audits 303 7.2.1 Criteria for Selecting Ongoing and Completed Studies 304 7.2.2 Areas of Expertise of the Facility 305 7.2.3 Establishment Inspections 305 7.2.4 Organization and Personnel (21 CFR 58.29, 58.31, 58.33) 305 7.2.5 Quality Assurance Unit (QAU; 21 CFR 58.35) 307 7.2.6 Facilities (21 CFR 58.41–58.51) 308 7.2.7 Equipment (21 CFR 58.61–58.63) 309 7.2.8 Testing Facility Operations (21 CFR 58.81) 310 7.2.9 Reagents and Solutions (21 CFR 58.83) 311 7.2.10 Animal Care (21 CFR 58.90) 311 7.2.11 Test and Control Articles (21 CFR 58.105–58.113) 312 7.2.12 Test and Control Article Handling (21 CFR 58.107) 313 7.2.13 Protocol and Conduct of Nonclinical Laboratory Study (21 CFR 58.120–58.130) 314 7.2.14 Study Protocol (21 CFR 58.120) 314 7.2.15 Test System Monitoring 314 7.2.16 Records and Reports (21 CFR 58.185–58.195) 314 7.2.17 Data Audit 316 7.2.18 General 316 7.2.19 Final Report Versus Raw Data 317 7.2.20 Specimens Versus Final Report 318 7.2.21 Refusal to Permit Inspection 318 7.2.22 Sealing of Research Records 318 7.2.23 Samples 319 7.3 Typical Inspections/Audits and Their Observations 320 7.4 Regulatory Challenges for Bioanalytical Laboratories 321 7.4.1 Introduction 321 7.4.2 Analysis of Current FDA Inspection Trends 324 7.4.3 Discussion and Analysis of Specific Potential FDA 483 Observation Issues 325 7.4.4 Method Validation Issues 325 7.4.5 Batch Runs Acceptance Criteria Issues 329 7.4.6 Events/Deviations Investigation/Resolution Issues 331 7.4.7 Test Specimen Accountability Issue 333 7.4.8 Recommendations to Support an Effective FDA Inspection Readiness Preparation 334 7.5 Handling and Facilitating GLP or GxP Audits/ Inspections 334 7.5.1 General Preparation for an Inspection 336 7.5.2 Why Are Audits/Inspections Needed and Conducted? 342 7.5.3 Written Policy in Place 342 7.5.4 Positions on Controversial Issues 343 7.5.5 The Inspection Coordinator 344 7.5.6 Follow-Up Procedures 348 7.5.7 Summary 349 References 351 8 Current Strategies and Future Trends 353 8.1 Strategies from General Laboratory and Regulatory Perspectives 354 8.2 Strategies from Technical and Operational Perspectives 356 8.3 Biological Sample Collection, Storage, and Preparation 360 8.3.1 Sample Collection and Storage 360 8.3.2 Sample Preparation Techniques 361 8.3.3 Off-Line Sample Extraction 364 8.3.4 On-Line Sample Extraction 364 8.4 Strategies for Enhancing Mass Spectrometric Detection 366 8.4.1 Enhanced Mass Resolution 368 8.4.2 Atmospheric Pressure Photoionization 369 8.4.3 High-Field Asymmetric Waveform Ion Mobility Spectrometry 370 8.4.4 Electron Capture Atmospheric Pressure Chemical Ionization 370 8.4.5 Mobile Phase Optimization for Improved Detection and Quantitation 371 8.4.6 Anionic and Cationic Adducts as Analytical Precursor Ions 372 8.4.7 Derivatization 372 8.5 Strategies for Enhancing Chromatography 374 8.5.1 Ultra-Performance Chromatography 375 8.5.2 Hydrophilic Interaction Chromatography for Polar Analytes 376 8.5.3 Specialized Reversed-Phase Columns for Polar Analytes 377 8.5.4 Ion-Pair Reversed-Phase Chromatography for Polar Analytes 378 8.6 Potential Pitfalls in LC–MS/MS Bioanalysis 378 8.6.1 Interference from Metabolites or Prodrugs due to In-Source Conversion to Drug 378 8.6.2 Interference from Metabolites or Prodrugs due to Simultaneous M + H+ and M + NH4+ Formation or Arising from Isotopic Distribution 379 8.6.3 Pitfall in Analysis of Two Interconverting Analytes due to Inappropriate Method Design 383 8.6.4 Matrix Effect 383 8.7 Trends in High-Throughput Quantitation 386 8.7.1 System Throughput 386 8.7.2 High-Speed HPLC 386 8.8 Trends in Hybrid Coupling Detection Techniques 388 8.9 Trends in Internal R&D and External Outsourcing 388 8.10 Trends in Ligand-Binding Assays and LC–MS/MS for Biomarker Assay Applications 397 8.11 Trends in Study Design and Evaluation Relating to Bioanalysis 399 8.12 Trends in Applying GLP to In Vitro Studies in Support of Regulatory Submissions 403 8.13 Trends in Global R&D Operations 404 8.14 Trends in Regulatory Implementations 407 8.14.1 Calibration Range and Quality Control Samples 407 8.14.2 Incurred Sample Reproducibility (Duplicate Sample Analysis) 408 8.14.3 LIMS and Electronic Data Handling, Security, Archiving, and Submission 409 8.15 Trends in Global Regulations and Quality Standards 412 8.16 Trends in Compliance with 21 CFR Part 11 414 8.16.1 21 CFR Part 11 Software Requirements 415 8.16.2 Building a Roadmap for Compliance with 21 CFR Part 11 415 8.16.3 Low Hanging Fruits in the Roadmap for Compliance with 21 CFR Part 11 416 8.17 Summary 419 References 421 9 General Terminologies of GxP and Bioanalytical Laboratories 431 9.1 General Terminologies for GxP and Bioanalytical Laboratories 431 9.2 GLP Basic Concepts and Implementation 469 9.2.1 The Study Protocol 470 9.2.2 Raw Data 471 9.2.3 The GLP Archive and the Archivist 472 9.2.4 Expansion of GLP Scope 473 9.2.5 OECD GLP 473 9.3 GLP Guidance Documents 474 9.3.1 FDA Guidance for Industry on Bioanalytical Method Validation 474 9.3.2 OECD GLP Guidance Documents 474 9.3.3 Swiss GLP Guidance Documents 475 References and Sources for Above Terminologies 475 Appendix A Generic Checklist for GLP/GXP Inspections/Audits 479 Appendix B General Template for SOP 489 Appendix C Typical SOPs for GLP/Regulated Bioanalytical Laboratory 493 Quality Assurance—GLP 493 Bioanalytical—GLP Laboratories 494 Appendix D Basic Equipment/Apparatus for Bioanalytical Laboratory 497 Appendix E Website Linkages for Regulated Bioanalysis 499 Index 503

Read more less

Book SynopsisThis two volume set provides a comprehensive account of the entire sequence of operations involved in discovering a drug through the actual delivery of the drug to clinicians and medical practitioners.Table of ContentsContributors. Preface. 17 Bioactive Molecules in Medicinal Plants: A Perspective on Their Therapeutic Action (S. C. Taneja and G. N. Qazi). 17.1 Introduction. 17.2 Evolutionary Relationships Among Plants and Humans. 17.3 Traditional Wisdom. 17.4 Unique Libraries for Plants. 17.5 Drugs and Bioactive Molecules from Plants. 17.6 Synergism in Herbal Formulations. 17.7 Interactions Between Modern Drugs and Natural Products. 17.8 Bioavailability and Bioeffi cacy Enhancers. 17.9 Combination Therapies in Modern Drugs. 17.10 Role of Developments in Technologies and Analytical Tools. 17.11 Herbal Medicine: The Best Possible Route to Health Care. References. 18 Natural Products as an Inspiration for the Discovery of New High-Throughput Chemical Synthesis Tools (Steven V. Ley, Ian R. Baxendale, Deborah A. Longbottom, and Rebecca M. Myers). 18.1 Introduction. 18.2 Solid-Supported Reagents as Tools in Natural Product Synthesis. 18.3 Multistep Use of Supported Reagents in Natural Product Synthesis. 18.4 Conclusions. References. 19 Insulin Sensitizers: Emerging Therapeutics (Braj B. Lohray and Vidya B. Lohray). 19.1 Introduction. 19.2 Therapeutic Interventions. 19.3 Discovery of Insulin Sensitizers. 19.4 Journey Toward New Drugs. 19.5 Conclusions. References. 20 Criteria for Industrial Readiness of Chiral Catalysis Technology for the Synthesis of Pharmaceuticals (Raymond McCague and Ian C. Lennon). 20.1 Introduction. 20.2 Criteria for Technology Readiness. 20.3 Examples of Industrially Ready Chiral Catalytic Technologies and Their Application. 20.4 How Industrially Ready Technology Can Deliver Commercial Advantages. 20.5 Conclusions. References. 21 Enantioselective Synthesis of Propargyl Alcohols as Multifunctional Synthons (J. S. Yadav and S. Chandrasekhar). 21.1 Introduction, 141 21.2 Asymmetric Reduction of Prochiral α, β-Alkynyl Ketones, 142 21.3 Addition of Acetylenic Anion to Carbonyl Carbon, 148 21.4 Desymmetrization and Enzymatic Strategies for Chiral Propargyl Alcohol Synthesis. 21.5 β-Elimination Strategy and Miscellaneous Approaches. 21.6 Conclusions. References. 22 Carbohydrates: From Chirons to Mimics (G. V. M. Sharma and Palakodety Radha Krishna). 22.1 Introduction. 22.2 Synthetic Strategies for C-Glycosides. 22.3 Synthetic Strategies for Carbon-Linked Disaccharides and Pseudosaccharides. References. 23 Meeting the Challenges of Process Development and Scale-up of Active Pharmaceutical Ingredients (Yatendra Kumar and B. Vijayaraghavan). 23.1 Introduction. 23.2 Process Development Cycle. 23.3 Conclusions. References. 24 Importance of Polymorphs and Salts in the Pharmaceutical Industry (Bipin Pandey, Vidya B. Lohray, and Braj B. Lohray). 24.1 Introduction. 24.2 Drug Discovery and Development. 24.3 Salt Selection. 24.4 Pseudopolymorphs. 24.5 Analytical Tools. 24.6 Process Development. 24.7 Formulation Development. 24.8 Regulatory Concerns. 24.9 Patent Implications. 24.10 Predictions and Uncertainties. 24.11 Conclusions. References. 25 Role of Outsourcing in Drug Manufacture (Peter Pollak). 25.1 Introduction. 25.2 Outsourcing in the Pharmaceutical Industry. References. 26 Regulation-Driven Process Chemistry (Shrikant V. Kulkarni). 26.1 Introduction. 26.2 Chemical Industry Regulatory Guidelines. 26.3 Manufacturing Techniques in Process Chemistry. 26.4 Effects of Pesticide Industry Regulation. 26.5 Efforts at Denitrifi cation. 26.6 Evolution to Green Chemistry. References. 27 Chemical Process Scale-up Tools: Mixing Calculations, Statistical Design of Experiments, and Automated Laboratory Reactors (Andrei A. Zlota). 27.1 Chemical Process Scale-up Challenges. 27.2 Case Study: Development of an Active Pharmaceutical Ingredient Crystallization Process. 27.3 Case Study: Determination of a Scale-up Factor for the Bourne III Reactive System. 27.4 Conclusions. References and Notes. 28 Library Quality Metrics (Richard L. Wife and Johan Tijhuis). 28.1 Drug Discovery and Development. 28.2 Compound Libraries. 28.3 Library Metrics. 28.4 Conclusions. 29 Tying a GABA from Copenhagen to Chicago: The Chemistry of Tiagabine (Mukund S. Chorghade, Mahendra N. Deshpande, and Richard J. Pariza). 29.1 Introduction. 29.2 Synthesis of Symmetrical Analogs: Tiagabine. 29.3 Synthesis of Unsymmetrical Analogs: Desmethyltiagabine. 29.3.1 Syntheses of Regioisomers of Tiagabine. 29.3.2 Human Metabolite of Tiagabine: 5-Hydroxytiagabine. 29.4 Attempted Biomimetic Synthesis of 5-Hydroxytiagabine. 29.5 Oxidative Degradation Products of Tiagabine. 29.6 Metalloporphyrins as Chemical Mimics of Cytochrome P450 Systems. References. 30 Building Contract Research Businesses Based on Integration of Basic and Applied Research (Mukund S. Chorghade, Mukund K. Gurjar, C. V. Ramana, and Sreenivas Punna). 30.1 Introduction. 30.2 Solving Real-World Problems. 30.3 Synthesis of Pharmaceutically Relevant Chiral Tetrahydrofurans. 30.4 Drugs for the Treatment of Skin Disorders. 30.5 Conclusions. References. 31 Principles and Practice of Clinical Drug Development (Colin Scott). 31.1 Introduction. 31.2 History of Ethical Medical Research. 31.3 History of the Regulation of Medical Research. 31.4 Preclinical Development. 31.5 Clinical Development. 31.6 Conclusions. Index.

Read more less

Book SynopsisProvides ethical guidelines much needed by the pharmaceutical industry. This book covers ethical issues involved in the testing and use of pharmaceuticals on humans, focusing on the issues surrounding the pharmaceutical industry and not medicine in general.Trade Review"...it will give the uninitiated a feel for the range of ethical isues..." (Mental Health Care, February 2003) "...a good introduction to the ethics surrounding pharmaceuticals..." (Pharmaceutical Physician, March 2003) "...the core question: should you read this book...definitely yes...the book stimulates our thinking and helps the reader to define and outline the many dilemmas in health care..." (Pharm World Sci, Vol. 25, No. 2, 2003)Table of ContentsList of Contributors. Preface. Foreword. 1. The Basis of Ethics (Jon Merrills). 2. Principles of Ethics Focusing on the Patient (Andrew Edgar). 3. Ethical Rationalism Applied to Pharmaceuticals (R.P. Dessing). 4. The Etihcs of the Drug Discovery and Development Process (Roger G. Bolton). 5. Informed Conset: Reconsideration of its Structure and Role in Medicine (Jan Payne). 6. Clinical Trials of Pharmaceuticals: Ethical Aspects (Olivier Chassany, Martin Duracinsky and Isabelle Mahé). 7. Can We Afford the Medicines We Need: An Ethical Dilemma? (Roger Walker). 8. Physician Choice or Patient Choice: Ethical Dilemmas in Science and Politics (Andrew Edgar). 9. The Economics of Drug-Related Morbidity and Mortality: Ethical Considerations (J. Lyle Bootman and Amy J. Grizzle). 10. Holistic Approach in Choice of Pharmaceutical Agents: Ethical Responsibilities (Sam Salek). 11. Ethical Values in the Treatment of Depression and Anxiety (John Lilja, Sam Larsson, David Hamilton and Mia Bauer). 12. Ethical Promotion and Advertising of Medicines: Where Do We Draw the Line? (Ivor Harrison). 13. Ethical Problems of Drug Categorization for Reimbursement (Chris Good). Index.

Read more less

Book SynopsisThis book presents both an overview and forward assessment of medical device materials and test methods. Highlighting the complex problem of host responses and related issues which may restrict the accuracy and reliability of existing test methodology, the book provides an unbiased appraisal of the requirements for biocompatibility and the approaches that have been developed to evaluate it.Table of ContentsBiocompatibility Standards: An International Overview (D. Marlowe, et al.). The Role of Material Standardisation and Method Validation in Evaluating Biocompatibility (J. Braybrook). Biodegradation and Toxicokinetic Studies (D. Gott). The Surface Analysis of Polymeric Biomaterials (M. Davies, et al.). Sterilisation Processes and Residuals (V. Dorman-Smith). Cytotoxicity (M.-F. Harmand, et al.). Interactions with Blood (J. Anderson). Genotoxicity, Carcinogenicity and Reproductive Toxicity (R. Eloy & N. Weill). Explant Retrieval and Analysis (J. Butany). Assessment of Biological Safety - Risk Analysis (J. Tinkler). Index.

Read more less

Book SynopsisTable of ContentsPreface to the Second Edition. Preface to the First Edition. Introduction. Electronics. Modulation Including Blocking Oscillation. Plastics and Other Materials. Pressure Sensing and Transmission. Temperature Sensing and Transmission. Bioelectric and Chemical Electrode Potentials. Multichannel Transmission and Fetal Studies. Sensors and Transmitters for Other Variables. Frequency and Antenna Selection. Receivers and Demodulators. Calibration and Response Control. Passive Transmission. Field Work. Aquatic Animals. Inward Power and Telestimulation. Related Methods. Zoo Exhibits. Human Studies and Clinical Applications. Appendix 1: Antenna Turns. Appendix 2: Frequency Choice. Appendix 3: Legal Factors. Appendix 4: Laboratory Experiment on Transmitter Construction. Appendix 5: Phaselock Loop Receiver. Appendix 6: Stable Temperature-Compensated Oscillator. References. General Reading. Index. About the Author.

Read more less

Book SynopsisPresents up-to-date coverage of routine procedures and their complications as well specialized procedures, quality and infection control, state-of-the-art equipment, medical terminology, ethical and legal issues, body systems, and related diagnostic laboratory tests. Videos, animations, and review questions online help you to excel.Table of Contents PART ONE PHLEBOTOMY AND THE HEALTHCARE FIELD 1. Phlebotomy and the Healthcare Delivery System 2. The Clinical Laboratory 3. Safety and Infection Control PART TWO BODY SYSTEMS 4. Basic Medical Terminology 5. Basic Anatomy and Physiology 6. The Circulatory System PART THREE PHLEBOTOMY TECHNIQUES 7. Venipuncture Equipment 8. Routine Venipuncture 9. Pre-examination Variables and Venipuncture Complications 10. Special Blood Collection 11. Dermal Puncture 12. Arterial Blood Collection PART FOUR ADDITIONAL TECHNIQUES 13. Point-of-Care Testing 14. Additional Duties of the Phlebotomist PART FIVE QUALITY PHLEBOTOMY 15. Ethical and Legal Issues 16. Quality Management in Phlebotomy APPENDIX A: Common Laboratory Tests and the Collection Tube Requirements APPENDIX B: Answers to Study Questions APPENDIX C: Answers to Clinical Situations APPENDIX D: Abbreviations APPENDIX E: English-Spanish Phrases for Phlebotomy GLOSSARY INDEX

Read more less

Book SynopsisThe most popular teaching text on laboratory data for pharmacy students and go-to reference for pharmacists in therapeutic practice.Now in its seventh edition, Basic Skills has been expanded and updated to cover new drugs, research, and therapeutic approaches. Written by 40 established clinicians and pharmacy faculty members and reviewed by additional experts, it is designed to make all information clear and quickly accessible. Minicases provide clinical scenarios for using tests and managing patients, and quickview charts throughout offer clear interpretations of lab results.The indispensable guide to interpreting clinical laboratory data.New to this edition: A new chapter on nutrition support Significant updates to all chapters Expanded chapters on Pharmacogenomics and Cardiology Additional section on Infectious Diseases covering Bacteria, and Fungi, Viruses and Mycobacteria Learning points conclude each chapter and highlight key concepts about the laboratory tests 25 chapters divided into three sections: Basic Concepts and Test Interpretations; System Disorders and Diagnostic Tests; and Tests for Special Populations Complex but critical skills are required for clinical pharmacists to effectively use lab data in screening for or diagnosing diseases and in monitoring the safety and effectiveness of treatment. As the only book of its kind specifically written for pharmacists by pharmacists, Basic Skills makes it easier to make accurate and critical decisions based on laboratory data.

Read more less

Book SynopsisTraditional Chinese Medicine (TCM) practitioners need to have an understanding of Western medical testing to recognize when laboratory tests are required and to interpret test results that are brought to them by patients. This book is an essential reference for the TCM classroom and clinic that teaches how to use and understand conventional lab testing in the treatment and referral of patients.Focusing on symptoms that commonly present in TCM practices, the book groups the lab tests by diseases or systems. Within each chapter are TCM case studies and perspectives, as well as multiple choice quizzes that test the reader's knowledge. Co-written by a doctor of Western medicine and an acupuncture physician, the book aims to familiarize TCM practitioners with the terminology and methodology of lab tests, bridging the gap between Eastern and Western schools of medicine and promoting an integrative approach to improve the overall care of the patient.Trade ReviewCommon Laboratory Tests Used by TCM Practitioners should be in every practitioner's office, every school library and part of acupuncture programs. The patient expects it. Society needs it. The book is arranged by disease and system. This approach is enhanced for learners with clear and pertinent background information which services the acupuncturist's needs perfectly. -- William R. Morris, PhD, DOAM, President, AOMA Graduate School of Integrative Medicine, Austin, TexasDoctors of TCM in China include two years of modern medical sciences as part of their training. They routinely order blood tests in the clinic to help with differential diagnosis, as well as monitoring the patient's prognosis using Chinese herbal medicine. As TCM practitioners in the West treat complicated internal disorders, it is important for them to understand conventional blood tests from other doctors, as well as order their own tests. Doctors Banerjee and Captain have written an extraordinary and thorough training manual on the use of common lab tests in a TCM practice. It is destined to become a standard text on the subject in our schools and clinics. -- Jake Paul Fratkin, OMD, L.Ac, author of Essential Chinese FormulasTable of ContentsPreface. 1. Complete Blood Count (CBC). 2. Hemoccult. 3. Kidney and Urine. 4. Electrolytes. 5. Glucose Metabolism and Diabetes Mellitus. 6. Liver Function. 7. Lipids. 8. Thyroid and Endocrinology. Practice Questions. Further Reading. Glossary.

Read more less

Book Synopsis

Read more less

Book SynopsisIn a unique way, the laboratory professionalist's knowledge about the molecular diagnostics of infectious diseases is connected with the clinician's practical experience. The increasing prevalence of infectious diseases makes correct diagnosis, ordering the right tests, quality control and correct interpretation of the results even more important. The possible pathogens are discussed in the second part according to the specific symptoms or to where the infection is located in the body. For clinicians and laboratory professionalists Up-to-date diagnostics of all infectious diseases Molecular diagnostics, diseases, choice of methods Specific pathogens in alphabetic order Tables and flow chartsTable of Contents1. General Information - Materials recommended for specific pathogens - Stability of the materials after collection - Extraction of nucleic acids - Amplification and detection methods - Quality assurance and quality control - Interpretation of the results 2. Specific Applications - HIV - Hepatitis (HBV+HDV, HCV, other Hepatitis viruses) - Pathogens relevant in transplantation medicine - Respiratory tract pathogens (viruses and bacteria) - Gastrointestinal tract pathogens (viruses and bacteria) - Central nervous system pathogens (viruses and bacteria) - Sexual Transmitted Diseases

Read more less

Book SynopsisThis volume comprises the invited plenary lectures and contributed papers presented at the WorldMedLab and the EuroMedLab in Berlin, May 2011 with more than 5.000 participants. The contributions in this volume provide a valuable and wide-ranging overview of current research in Laboratory Medicine and cognate disciplines.Special focus is given to Aging Society (neurological diseases), Tumors, Organ specific dysfunctions and Future of Laboratory Medicine.

Read more less

Book SynopsisHerbal supplements are available without prescription in many countries throughout the world and accounting for over $30 billion U.S dollar in sale. A majority of U.S population (25-40%) use herbal supplements while alternative medicines are major forms of therapy in third world countries used by as much as 80% population. Contrary to the popular belief that herbal remedies are safe and effective, many herbal supplements have known toxicity and unexpected laboratory test results may be the early indications of such toxicity. In addition, some herbal products such as St. John’s wort can interact with many Western drugs causing increased clearance of such drugs and hence treatment failure. This monograph would provide information on how herbal supplements affect laboratory test results thus patient’s safety. This monograph would provide a comprehensive and concise practical guide for laboratory professionals, physicians and other health care professionals. The emphasis of this monograph is to provide clinically relevant information rather than discussing in detail mechanisms of such effect, although brief explanations would be provided for such unexpected test results.Table of Contents1. Commonly used herbal supplements 2. Abnormal liver function tests due to use of herbal supplements. 3. Kelp and thyroid panel 4. Interferences in digoxin immunoassays by various herbal supplements 5. Interaction of St. John’s wort with various drugs 6. Which herbs to avoid with warfarin therapy? 7. Interaction of ginseng, ginkgo, garlic and ginger supplements with various drugs 8. Interaction of various fruit juices with drugs 9. Heavy metal toxicity due to use of oriental and Ayurvedic medicines 10. Unexpected laboratory test results due to contamination of herbal supplements with Western drugs 11. Moderately toxic and dangerous herbs

Read more less

Book SynopsisDefined as red blood cell break down and the release of hemoglobin and intracellular contents into the plasma, hemolysis can seriously impact patient care as well as the laboratory's reputation through its affect on test results. Therefore, the European Preanalytical Scientific Committee, in collaboration with the International Federation of Clinical Chemistry Working Group on Patient Safety, have designed a questionnaire to collect data on prevalence and management of hemolytic specimens referred to the clinical laboratories for clinical chemistry testing. This book will help identify the areas where hemolysis occurs most frequently, which can, in turn, guide further analysis about why it is occurring. Once these elements are known, practices and procedures can be implemented to dramatically reduce hemolysis and avoid erroneous laboratory results affecting patient care and increasing laboratory costs.

Read more less

Book SynopsisThe goal of clinical laboratories is to produce accurate information for clinical decision making in medicine. More than half of the medical decisions made depend on clinical laboratory tests. Patient safety represents an important and critical problem for laboratories. They need to assure that the information they deliver to physicians is accurate, and therefore safe for clinicians to use. Endogenous compounds can interfere with laboratory tests, decreasing accuracy and threatening patient safety. Elevated bilirubin (bilirubinemia) and elevated lipids (lipemia) are common conditions that cause significant interferences with laboratory results. Clinicians depend on laboratories to detect these endogenous interferences. Laboratories must have a means to detect these endogenous interferences, make decisions about reporting results, and evaluate their impact. Most clinical pathology books provide only an abbreviated introduction to the subject, or provide a long list of references, without the necessary foundation for evaluating their significance. Package inserts typically provide scant information. This book provides the empirical and theoretical foundation for these interferences, describes the clinical settings where they occur, and explains their evaluation and detection, allowing the laboratory to interpret the available data on interferences and make the appropriate decision to effectively report test results while protecting patient safety.

Read more less

Book SynopsisThe prevalence of infectious diseases is worldwide increasing. Therefore, detection methods for infectious pathogens change quickly. In the 3rd edition of Kessler's Molecular Diagnostics of Infectious Diseases laboratory professionalists get valueable information about the current diagnostic methods, tipps and tricks in terms of sample processing, quality control, and interpretation of the results. For clinicians the book is a valuable aid for decision-making in ordering appropriate tests as well as in assuring the necessary quality of the sample material.Table of Contents 1 Choice of adequate sample material 2 Stability of the specimen during preanalytics 3 Quality assurance and quality control in the routine molecular diagnostic laboratory 4 Extraction of nucleic acids 5 Amplification and detection methods 6 Interpreting and reporting molecular diagnostic tests 7 Human immunodeficiency virus 8 Hepatitis viruses 9 Pathogens relevant in transplantation medicine 10 Pathogens in lower respiratory tract infections 11 Molecular diagnosis of gastrointestinal pathogens 12 Pathogens relevant in the central nervous system 13 Pathogens relevant in sexually transmitted infections Index

Read more less

Book SynopsisThe preanalytical phase is an important component of Laboratory medicine and errors arising in this phase affect the validity of laboratory results. In this book, physicians and clinical staff have access to valuable information about the current preanalytical variables and factors (patient preparation, sample collection, handling and processing before analysis).Table of ContentsPreface List of Contributing authors 1. General Part 1.1. Introduction and History of the Preanalytical Phase Guder W.G. 1.2. From Diagnostic Strategies to Guidelines and Pathways. Benefits and Limitations of Laboratory Diagnostic Pathways. Hoffmann G, Aufenanger J, Födinger M, Cadamuro J, von Eckardstein A, Hofmann W. 1.3. Definition of Influence and Interference Factors in the Preanalytical Phase. Guder W.G. 1.4. Extraanalytical Procedures and their Management in Total Turnaround Time Guder W.G.,Wisser H. 2. Types of Samples and Anatomic Site of Origin 2.1. What site of Sampling, Arterial , Venous or Capillary Blood ? Guder W.G., Hagemann P 2.2. Special Preexamination Conditions in Newborns and Pediatric Patients.Vassault A, Couderc R 2.3. Venous Blood Sampling (Phlebotomy) Guder WG, Cornes M. 2.4. Arterial Sampling of Blood Guder W.G., Hagemann P. 2.5. Capillary Sampling of Blood Cornes M, Guder W.G. 2.6. Plasma or Serum? Which Anticoagulant to Use?Guder W.G., Narayanan S. 2.7. Spot or Timed Urine, When and Why? Guder W.G., Delange J 2.8. When are other Body Fluids to be Analyzed Guder W.G. 2.9. Who is doing Phlebotomy in Europe?Simundic A.M. 3. Biological Variables Influencing Laboratory Results 3.1 Age and Gender Differences; unavoidable Influences on Laboratory Results Guder W.G. ,Narayanan S. 3.2 Variables during Sampling Guder W.G., Narayanan S. 3.3 Food, Drinks and Smoking Narayanan S, Guder W.G. 3.4 Effects of Herbs Narayanan S., Young D.S 4. Source and Nature of Interferences of Analytical Procedures. 4.1 The Hemolytic Sample Guder W.G., daFonseca-Wollheim F, Schmitt Y.M., Töpfer G. 4.2 The Lipemic Sample Guder W.G., Nikolac N,Schmitt Y.M., Töpfer G. 4.3 The Icteric Sample Guder W.G., da Fonseca-Wollheim F., Schmitt Y.M., Töpfer G. 4.4 Drug Interferences. Sonntag O. 4.5 Interferences from Blood Sampling Device Materials on Clinical Assays. Part 1 Bowen R.A.R. Adcock - Funk D. 4.6 Interferences from Blood Sampling Device Materials on Clinical Assays, Part 2 Bowen R.A.R., Adcock - Funk D. 5. Sampling Techniques and Professions 5.1 Materials and Techniques of Sampling Blood and other Body Fluids, Contributions of Greiner- Bio-One.Ivanov H, Präuer J, Schimpl M, Castelo-Rose G, Wiesner C, Ehrenfellner T. 5.2 Materials and Techniques of Sampling Blood from Sarstedt. C. Seipelt 5.3 BD Preanalytical Systems - Diagnostic Sample Collection Schlueter K., Church S. 6. Specimen Processing in the Preanalytical Phase 6.1 Sample Transport, Treatment after Arrival, Storage and Disposal Guder W.G., Narayanan S. 6.2 Preanalytical Workflow Techniques and Procedures Streichert T., von Meyer A. 7. Preanalytical Variables and Rules in Specific Fields of Medical Laboratory Diagnostics 7.1 Haemostaseology Dempfle C-E., Toepfer G. 7.2 Haematology including Flow Cytometry of Blood Cells Narayanan S.,Guder W.G. 7.3 Blood Gases, Ions and Electrolytes Simundic A-M. 7.4 Clinical Chemistry: Metabolites, Enzymes, Hormones and Proteins Narayanan S., Guder W.G.. 7.5 Preanalytical Variables in Therapeutic Drug Monitoring Narayanan S,, Agrawal Y. 7.6 Preanalytical Variables in Microbiology Narayanan S, Schuetz N. 7.7 Biobanking Leichtle A., Findeisen P. 8. Quality Assurance and Auditing of the Preanalytical Phase 8.1 Auditing of the Preanalytical Phase Petersmann A., Schlüter K., Nauck M. 8.2 Internal Quality assurance for Preanalytical Phase Cadamuro J. 8.3 External Quality Assurance for the Preanalytical Phase Kristensen G.B.B., Aakre K.M., Kristoffersen A.H., Sandberg S. 9. Annex: Samples and Stability of Analytes Index

Read more less

Book SynopsisThe global medical process is a chain of different medical multidisciplinary procedures. The success in global Patient Safety will depend on the Safety of the consecutive medical processes that intervene in this complex system. Laboratory data is an essential part of health care, indeed it is used in 70% of clinical decisions. Inappropriate laboratory test over requesting is extremely frequent. The prevalence of under requesting has been less studied. The consequences of under requesting are clear, we are missing a diagnosis. Inappropriate over requesting can result not only in a problem of cost but also in a problem regarding patient safety. Additionally, another important consequence of inappropriate tests over requesting is that such amount of unnecessary tests has probably contributed to a significant increase in the volume of those over the last years. In all, there is general consensus that the inadequacy of test requesting must be corrected through strategies and monitored over time through indicators to assure the optimal laboratory contribution to clinical decision-making and patient safety.

Read more less

Book SynopsisThe prognosis of a disease often depends on the timing of therapeutic invention, which in turn strongly relies on a reliable and quick diagnosis. Laboratory diagnostic pathways are algorithms that give structure to the diagnostic process, thereby minimizing the risk of mistreatment, shortening the hospital stay, and lowering the cost for treatment. This book offers 70 diagnostic algorithms that lead physicians and laboratory personnel through the diagnostic process in a step-by-step fashion. In Part One, general basics, infrastructure, and economic aspects are discussed and tipps for implementation are given. Part Two introduces screening methods for cases without a suspected diagnosis as well as specific pathways for stepwise diagnosis of the most common diseases, accompanied by information on pathophysiology, preanalytical measures, implementation, and interpretation of results.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

Book SynopsisEssentially a practical manual with up-to-date contributions and key references by experts to the diagnostic characteristics of the bacteria likely to be encountered in public health and hospital microbiology laboratories as well as in medical and veterinary practice.Trade Review'In conclusion this excellent book has retained the best of the old and combined it with the new. It is a must for every clinical laboratory and at only £40, represents excellent value for money.' Tim Wyatt, Association of Clinical Microbiologists News'… this practical manual, which has been the standard diagnostic text since the mid-1960s, continues to be the standard reference text for bacteriology.' The Bulletin of The Royal College of PathologistsTable of ContentsForeword; Introduction; 1. Classification and nomenclature; 2. Culture media: constituents and sterilization; 3. Principles of isolation; 4. Bacterial characters and characterization; 5. Theory and practice of bacterial identification; 6. Characters of Gram-positive bacteria; 7. Characters of Gram-negative bacteria; 8. Taxonomy in theory and practice; 9. Bacterial identification by cards; 10. Bacterial identification by computer; 11. Quality control in microbiology; 12. Reconciliation of approaches to bacterial systematics; Glossary; References; Index.

Read more less

Book SynopsisAny scientist or technician involved in pre-clinical drug studies knows that infusing animal models with test substances is no simple matter, especially if one wants to do it humanely as well as guarantee results that are not compromised by the procedure. The challenge becomes compounded if one is employing a variety of species. What works for a rat or mouse does not necessarily work for a rabbit or primate. The Handbook of Pre-clinical Continuous Intravenous Infusion answers the needs of researchers and technicians by providing complete instructions for a wide range of infusion techniques delivered to several species. With sections devoted to rats, mice, rabbits, dogs, mini-pigs, and nonhuman primates (both large and small), this thorough text gives step-by-step instructions for the use of a variety of techniques, and equipment. It includes procedures for multidose infusion toxicity and reproductive toxicology studies, and provides guidance on the use of a variety of equipmentTrade Review"…an excellent buy for anyone involved in drug development, risk assessment or within drug licensing agencies and in academic research. …This book represents a benchmark achievement for this technique …it will become the standard for many years to come" British Toxicology Society Newsletter Table of ContentsIntroduction. Femoral Cannulation Using the Jacket/Harness Model in the Rat. Femoral Cannulation Using the Tail Cuff Exteriorisation Method in the Rat. Tethering and the Implanted Button Model in the Rat. Multidose Infusion Toxicity Studies in the Rat. Reproductive Infusion Toxicity Studies in the Rat. Femoral Cannulation Using the Tail Cuff Model in the Mouse. Multidose Infusion Toxicity Studies in the Mouse. Jugular Cannulation and Efficacy Studies in the Mouse. Femoral Cannulation of the Rabbit for Reproductive Toxicity Studies. Jugular Cannulation of the Rabbit for Reproductive Toxicity Studies. Jugular Cannulation of the Dog. The Non-Ambulatory Model in Dog Multidose Infusion Toxicity Studies. The Ambulatory Model in Dog Multidose Infusion Toxicity Studies. Surgical Preparation of the Large Primate. Multidose Infusion Toxicity Studies in the Large Primate. Surgical Preparation and Multidose Infusion Toxicity Studies in the Marmoset. Surgical Preparation of the Mini-Pig. Multidose Infusion Toxicity Studies in the Mini-Pig. Reproductive Toxicity Studies in the Mini-Pig. Common Pathological Findings in Continuous Infusion. The Use of Mini-Osmotic Pumps in Continuous Infusion Studies. The Contribution of Vehicles, Rates of Administration and Volumes to Infusion Studies. Equipment for Continuous Intravenous Infusion.NTI/Sales Copy

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less